9-136011776-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_144653.5(NACC2):c.1504G>A(p.Asp502Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000607 in 1,530,918 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_144653.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
NACC2 | NM_144653.5 | c.1504G>A | p.Asp502Asn | missense_variant | 6/6 | ENST00000277554.4 | NP_653254.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
NACC2 | ENST00000277554.4 | c.1504G>A | p.Asp502Asn | missense_variant | 6/6 | 1 | NM_144653.5 | ENSP00000277554.2 | ||
NACC2 | ENST00000371753.5 | c.1504G>A | p.Asp502Asn | missense_variant | 5/5 | 1 | ENSP00000360818.1 |
Frequencies
GnomAD3 genomes AF: 0.0000526 AC: 8AN: 152204Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000137 AC: 21AN: 153484Hom.: 0 AF XY: 0.000152 AC XY: 13AN XY: 85706
GnomAD4 exome AF: 0.0000617 AC: 85AN: 1378596Hom.: 0 Cov.: 29 AF XY: 0.0000678 AC XY: 46AN XY: 678194
GnomAD4 genome AF: 0.0000525 AC: 8AN: 152322Hom.: 0 Cov.: 33 AF XY: 0.0000671 AC XY: 5AN XY: 74486
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 17, 2024 | The c.1504G>A (p.D502N) alteration is located in exon 6 (coding exon 5) of the NACC2 gene. This alteration results from a G to A substitution at nucleotide position 1504, causing the aspartic acid (D) at amino acid position 502 to be replaced by an asparagine (N). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at